SCHEMBL9103516

SCHEMBL9103516

CC([SiH3])C(Cl)CCCCCCCCCCCCCCCCCl

nearest known ligand 0.42

Predicted protein targets (top 3)

geneUniProtsupporting neighboursconfidence
TSHR P16473 2/20 0.42
ALDH1A1 P00352 1/20 0.42
TDP1 Q9NUW8 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6882237 0.90
SCHEMBL28420451 0.80 TSHR (0.39) TSHRALDH1A1TDP1
SCHEMBL9344838 0.79 TSHR (0.40) TSHRALDH1A1TDP1
SCHEMBL6577894 0.77 TSHR (0.35) TSHRALDH1A1TDP1
SCHEMBL29109626 0.76 ALDH1A1 (0.38) TSHRALDH1A1TDP1
SCHEMBL7862792 0.74 TSHR (0.43) TSHRALDH1A1TDP1
SCHEMBL10395460 0.74 ALDH1A1 (0.36) TSHRALDH1A1TDP1
SCHEMBL3797790 0.74 TSHR (0.43) TSHRALDH1A1TDP1
SCHEMBL686673 0.74 ALDH1A1 (0.36) TSHRALDH1A1TDP1
SCHEMBL10482157 0.74

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 12 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-4736861-A1 ORAL COMPOSITION CONTAINING INORGANIC POROUS BODY Tanabe Pharma Corporation (JP) 2026-05-06 EP disclosed
CN-110248724-B Nucleic acid based data storage 特韦斯特生物科学公司 2022-11-18 CN disclosed
US-9884970-B2 Coating composition for preventing collapse of capacitor YOUNG CHANG CHEMICAL CO., LTD (KR) 2018-02-06 US disclosed
EP-2468798-B1 SOLID ELECTROLYTE MEMBRANE FOR FUEL CELL AND PROCESS FOR PRODUCING SAME CENTRAL GLASS CO LTD (JP) 2017-03-08 EP disclosed
US-20150274991-A1 COATING COMPOSITION FOR PREVENTING COLLAPSE OF CAPACITOR YOUNG CHANG CHEMICAL CO., LTD (KR) 2015-10-01 US disclosed
US-8771642-B2 Active particles for bio-analytical applications and methods for their preparation Alma Mater Studiorum—Universita' di Bologna (IT) 2014-07-08 US disclosed
WO-2014092424-A1 COATING COMPOSITION FOR PREVENTING COLLAPSE OF CAPACITOR 영창케미칼 주식회사 (KR) 2014-06-19 WO disclosed
US-8445551-B2 Solid electrolyte membrane for fuel cell and process for producing same CENTRAL GLASS COMPANY, LTD. (JP) 2013-05-21 US disclosed
EP-2468798-A1 SOLID ELECTROLYTE MEMBRANE FOR FUEL CELL AND PROCESS FOR PRODUCING SAME Central Glass Company, Limited (JP) 2012-06-27 EP disclosed
US-20120142791-A1 Solid Electrolyte Membrane for Fuel Cell and Process for Producing Same CENTRAL GLASS COMPANY, LIMITED (JP) 2012-06-07 US disclosed
US-20110274621-A1 Active Particles for Bio-Analytical Applications and Methods for Their Preparation ALMA MATER STUDIORUM-UNIVERSITA'DI BOLOGNA (IT) 2011-11-10 US disclosed
US-20110262356-A1 Active Particles for Bio-Analytical Applications and Methods for Preparation Thereof CYANAGEN S.R.L. (IT) 2011-10-27 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20120142791-A1 Solid Electrolyte Membrane for Fuel Cell and Process for Producing Same LNPK, KCNJ1, EPCAM TSHR 4140/4885ALDH1A1 2851/4885TDP1 4558/4885
US-20110262356-A1 Active Particles for Bio-Analytical Applications and Methods for Preparation Thereof PHOSPHO1, EPX, PGLS TSHR 2674/4885ALDH1A1 1625/4885TDP1 1234/4885
US-20110274621-A1 Active Particles for Bio-Analytical Applications and Methods for Their Preparation PHOSPHO1, LIPA, ALG1 TSHR 3680/4885ALDH1A1 1297/4885TDP1 2495/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.